Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine alone for conscious sedation during ERCP
ChiCTR-IPR-17012543Phase 4Recruiting
- Sponsor
- The Second Affiliated Hospital of Dalian Medical University
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in pancreaticobiliary diseases comparing Dexmedetomidine sedation with Propofol target-controlled infusion (2 arms). Primary endpoints: SpO2, Respiratory rate and 4 more. Started Sep 2017; status: recruiting.
02
Drugs
dexmedetomidinepropofol
03
Conditions
pancreaticobiliary diseases
Beyond the preview
Go deeper on ChiCTR-IPR-17012543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17012543.